Nice for people of Johns stature to make those kind comments towards Dr Tanzi...
John Hardy is the Head of the Department of Molecular Neuroscience and Chair of Molecular Biology of Neurological Disease at the UCL Institute of Neurology.
ITM, What makes you feel there are safety concerns with Anavex ?
Nice for people of Johns stature to make those kind comments...
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $26.22M | |||
| Open | High | Low | Value | Volume |
| 0.5¢ | 0.5¢ | 0.5¢ | $7.5K | 1.5M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 57 | 63305651 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 38258482 | 22 |
View Market Depth
| Last trade - 10.00am 12/07/2024 (20 minute delay) ? |
| ATH (ASX) Chart |